Intervacc AB (publ)
IVACC
Rank in Stocks
#25666
Intervacc AB (publ) is a Swedish biotechnology company primarily engaged in the... Intervacc AB (publ) is a Swedish biotechnology company primarily engaged in the research and development of innovative vaccines designed to combat bacterial infections in animal health. The firm's vaccine pipeline targets various animals, including horses, piglets, and dairy cows, with its key product, Strangvac, specifically developed to prevent equine strangles. Beyond its current offerings, Intervacc is also advancing vaccines against Streptococcus suis and Staphylococcus aureus infections. In addition to vaccine development, the company distributes veterinary medicines and provides essential diagnostic services in veterinary bacteriology to clinics and stud farms. Headquartered in Hägersten, Sweden, Intervacc serves customers across the Nordic countries and the Baltic states.
Share Price
$0.06991141
Last synced: 2026-11-12
Market Cap
$23.83M
Change (1 day)
-12.32%
Change (1 year)
-26.07%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Intervacc AB (publ) (IVACC)
Category
Healthcare
EPS for Intervacc AB (publ) (IVACC)
EPS as of September 2026 TTM: $-0.03
According to Intervacc AB (publ)'s latest financial reports, its current EPS (TTM) is $-0.03. At the end of 2025 the company had an EPS of $-0.03, an increase over its 2024 EPS of $-0.08.
EPS history for Intervacc AB (publ) from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.03 | -0.67% |
| 2025 | $-0.03 | -62.44% |
| 2024 | $-0.08 | -50.51% |
| 2023 | $-0.16 | 47.98% |
| 2022 | $-0.11 | 88.83% |
| 2021 | $-0.06 | -0.88% |
| 2020 | $-0.06 | -14.31% |
| 2019 | $-0.07 | -23.94% |
| 2018 | $-0.09 | 3.44% |
| 2017 | $-0.08 | 50.45% |
| 2016 | $-0.06 | -9,450.00% |
| 2015 | 0.00 | -98.66% |
| 2014 | $0.04 | -439.39% |
| 2013 | $-0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | 2,886.58% |
US
|
|
| $15.66 | -52,650.34% |
US
|
|
| $-7.07 | 23,624.83% |
US
|
|
| $-5.29 | 17,651.68% |
AU
|
|
| $12.73 | -42,825.50% |
BE
|
Questions about Intervacc AB (publ)'s earnings per share (EPS)
What is Intervacc AB (publ)'s earnings per share (EPS)?
Intervacc AB (publ)'s earnings per share (EPS) over the last twelve months is $-0.03, as of Sep 2026.
What was Intervacc AB (publ)'s earnings per share (EPS) in 2025?
In 2025, Intervacc AB (publ)'s earnings per share (EPS) was $-0.03, compared with $-0.08 in 2024.
How has Intervacc AB (publ)'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Intervacc AB (publ)'s earnings per share (EPS) was highest in 2025 ($-0.03) and lowest in 2023 ($-0.16).
How does Intervacc AB (publ)'s earnings per share (EPS) compare with similar companies?
Intervacc AB (publ)'s earnings per share (EPS) ($-0.03) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.